These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2244019)

  • 1. The importance of vocal cord mobility in T2 laryngeal cancer.
    Wiggenraad RG; Terhaard CH; Hordijk GJ; Ravasz LA
    Radiother Oncol; 1990 Aug; 18(4):321-7. PubMed ID: 2244019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of extension and impaired mobility in cancer of the vocal cord.
    Van den Bogaert W; Ostyn F; van der Schueren E
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):181-4. PubMed ID: 6833020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of T3 laryngeal carcinoma. Clinical evaluation after 50 Gy, is it of any value?
    Aanesen JP; Winther FO; Tausjø J
    Acta Otolaryngol Suppl; 1988; 449():141-4. PubMed ID: 3201940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of vocal cord fixation with respect to treatment in cancers of the supraglottis and pyriform sinus.
    Spaulding CA; Gillenwater A; Constable WC; Hahn SS; Kersh CR
    Laryngoscope; 1987 Dec; 97(12):1450-3. PubMed ID: 3683056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in T2 glottic cancer.
    Harwood AR; DeBoer G
    Cancer; 1980 Mar; 45(5):991-5. PubMed ID: 7260851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx.
    Gorphe P; Blanchard P; Breuskin I; Temam S; Tao Y; Janot F
    J Laryngol Otol; 2015 Sep; 129(9):903-9. PubMed ID: 26201253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients.
    Chevalier D; Laccourreye O; Brasnu D; Laccourreye H; Piquet JJ
    Ann Otol Rhinol Laryngol; 1997 May; 106(5):364-9. PubMed ID: 9153099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression after 50 Gy as a selection for therapy in advanced laryngeal cancer.
    Terhaard CH; Wiggenraad RG; Hordijk GJ; Ravasz LA
    Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):591-7. PubMed ID: 3138211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single Vocal Cord Irradiation: Image Guided Intensity Modulated Hypofractionated Radiation Therapy for T1a Glottic Cancer: Early Clinical Results.
    Al-Mamgani A; Kwa SL; Tans L; Moring M; Fransen D; Mehilal R; Verduijn GM; Baatenburg de Jong RJ; Heijmen BJ; Levendag PC
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):337-43. PubMed ID: 26264629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of surgery and radiotherapy in T1 and T2 glottic carcinomas.
    Ton-Van J; Lefebvre JL; Stern JC; Buisset E; Coche-Dequeant B; Vankemmel B
    Am J Surg; 1991 Oct; 162(4):337-40. PubMed ID: 1951884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prognostic significance of impaired vocal cord motility in patients with stage II glottic cancer treated with radiotherapy].
    Kowalska T; Reinfuss M; Walasek T; Dymek P; Weiss M; Skołyszewski J
    Otolaryngol Pol; 1997; 51(1):31-6. PubMed ID: 9518313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone.
    Bhateja P; Ward MC; Hunter GH; Greskovich JF; Reddy CA; Nwizu TI; Lamarre E; Burkey BB; Adelstein DJ; Koyfman SA
    Head Neck; 2016 Dec; 38(12):1832-1836. PubMed ID: 27299502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of impaired vocal cord mobility as a prognostic factor in T2 glottic carcinoma.
    McCoul ED; Har-El G
    Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):479-86. PubMed ID: 19451470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors identified by Cox multivariate analysis of surgically treated 1018 laryngeal cancer patients].
    Du Q; Ji WY; Guan C; Xu QY
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):211-3. PubMed ID: 16875608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis.
    Chen MF; Chang JT; Tsang NM; Liao CT; Chen WC
    Ann Otol Rhinol Laryngol; 2003 Oct; 112(10):904-11. PubMed ID: 14587984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early stage vocal cord cancer: results after external beam radiotherapy.
    Fanelle JW
    N J Med; 1997 Feb; 94(2):37-42. PubMed ID: 9040183
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiotherapy alone or combined with neck dissection for T1-T2 carcinoma of the pyriform sinus: an alternative to conservation surgery.
    Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ; Million RR
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1017-27. PubMed ID: 8262822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of indirect microlaryngo-stroboscopy in the follow-up care of patients with vocal cord carcinoma treated with primary irradiation].
    Wallesch B; Sieron J; Johannsen HS
    Laryngorhinootologie; 1991 Oct; 70(10):559-61. PubMed ID: 1741885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.